Benign metastasizing leiomyoma in femur and thigh with a history of uterine leiomyoma: A case report and literature review.
benign metastasizing leiomyoma
gonadotropin-releasing hormone agonist
hysterectomy
metastasis to femur
myomectomy
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
27
04
2020
revised:
08
09
2020
accepted:
18
10
2020
pubmed:
10
11
2020
medline:
22
6
2021
entrez:
9
11
2020
Statut:
ppublish
Résumé
Benign metastasizing leiomyoma (BML) is a rare disease that is characterized by well-differentiated smooth muscle tumors occurring extrauterine site in women with a history of uterine leiomyoma. The lung is the most common metastatic site for BML. A 48-year-old woman, who had histories of laparoscopic myomectomy and transabdominal total hysterectomy, visited an orthopedics complaining of a mass in her left thigh and difficulty in walking. Magnetic resonance imaging (MRI) and fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography revealed multiple mass lesions in her both thighs and left femur as well as both lungs. She was referred to our hospital for further examination. We diagnosed her tumors as BML according to histopathological analysis of tumor specimen. The left thigh tumor was resected and the treatment with gonadotropin releasing hormone agonist regressed the size of the residual tumors by approximately 30%. BML should be considered when multiple soft tissue tumors are found in women with a history of leiomyomas.
Types de publication
Case Reports
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
812-817Informations de copyright
© 2020 Japan Society of Obstetrics and Gynecology.
Références
Barnas E, Ksiazek M, Ras R, Skret A, Skret-Magierlo J, Dmoch-Gajzlerska E. Benign metastasizing leiomyoma: A review of current literature in respect to the time and type of previous gynecological surgery. PLoS One. 2017; 12: e0175875.
Steiner PE. Metastasizing fibroleiomyoma of the uterus: Report of a case and review of the literature. Am J Pathol. 1939; 15: 89-110 7.
Efared B, Atsame-Ebang G, Sani R et al. Unexpected pulmonary tumor: Metastasis from a benign uterine leiomyoma in a post-menopausal woman: A case report. BMC Res Notes. 2017; 10: 662.
Thukkani N, Ravichandran PS, Das A, Slater MS. Leiomyomatosis metastatic to the tricuspid valve complicated by pelvic hemorrhage. Ann Thorac Surg. 2005; 79: 707-709.
Rege AS, Snyder JA, Scott WJ. Benign metastasizing leiomyoma: A rare cause of multiple pulmonary nodules. Ann Thorac Surg. 2012; 93: e149-e151.
Lee HJ, Choi J, Kim KR. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: Clinical behavior and genomic changes supporting a transportation theory. Int J Gynecol Pathol. 2008; 27: 340-345.
Plaza JA, Perez-Montiel D, Mayerson J, Morrison C, Suster S. Metastases to soft tissue: A review of 118 cases over a 30-year period. Cancer. 2008; 112: 193-203.
Shibata H. Concept and overview of JSMO guidelines for the treatment of bone metastasis. Gan To Kagaku Ryoho. 2015; 42: 1338-1341.
Sawai Y, Shimizu T, Yamanaka Y, Niki M, Nomura S. Benign metastasizing leiomyoma and 18-FDG-PET/CT: A case report and literature review. Oncol Lett. 2017; 14: 3641-3646.
Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: A retrospective review of 212 cases. Eur J Nucl Med Mol Imaging. 2009; 36: 1944-1951.
Yuan X, Sun Y, Jin Y et al. Multiple organ benign metastasizing leiomyoma: A case report and literature review. J Obstet Gynaecol Res. 2019; 45: 2132-2136.
Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989; 249: 256-264.
Willeumier JJ, van der Linden YM, Dijkstra PD. Lack of clinical evidence for postoperative radiotherapy after surgical fixation of impending or actual pathologic fractures in the long bones in patients with cancer; a systematic review. Radiother Oncol. 2016; 121: 138-142.
Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994; 18: 535-558.
Mittal K, Demopoulos RI. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 2001; 32: 984-987.
Lewis EI, Chason RJ, DeCherney AH, Armstrong A, Elkas J, Venkatesan AM. Novel hormone treatment of benign metastasizing leiomyoma: An analysis of five cases and literature review. Fertil Steril. 2013; 99: 2017-2024.
Goto T, Maeshima A, Akanabe K et al. Benign metastasizing leiomyoma of the lung. Ann Thorac Cardiovasc Surg. 2012; 18: 121-124.
Rivera JA, Christopoulos S, Small D, Trifiro M. Hormonal manipulation of benign metastasizing leiomyomas: Report of two cases and review of the literature. J Clin Endocrinol Metab. 2004; 89: 3183-3188.
Silva I, Tome V, Oliveira J. Benign metastasising leiomyoma: A progressive disease despite chemical and surgical castration. BMJ Case Rep. 2012; 2012: bcr0120125505.
Hague WM, Abdulwahid NA, Jacobs HS, Craft I. Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma. Br J Obstet Gynaecol. 1986; 93: 455-460.
Ki EY, Hwang SJ, Lee KH, Park JS, Hur SY. Benign metastasizing leiomyoma of the lung. World J Surg Oncol. 2013; 11: 279.
Barber E, Eapen A, Mehta R et al. Benign metastasizing leiomyoma to the lung and spine: A case report and literature review. Case Rep Oncol. 2019; 12: 218-223.